MENU
+Compare
RENB
Stock ticker: NASDAQ
AS OF
Jun 5, 04:59 PM (EDT)
Price
$0.31
Change
+$0.01 (+3.33%)
Capitalization
53.36M

RENB Renovaro Forecast, Technical & Fundamental Analysis

Renovaro Inc is a biopharmaceutical company... Show more

RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RENB with price predictions
Jun 04, 2025

RENB in -7.01% downward trend, declining for three consecutive days on June 03, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RENB declined for three days, in of 293 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for RENB entered a downward trend on May 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on June 04, 2025. You may want to consider a long position or call options on RENB as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RENB advanced for three days, in of 256 cases, the price rose further within the following month. The odds of a continued upward trend are .

RENB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RENB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.604) is normal, around the industry mean (16.306). P/E Ratio (0.000) is within average values for comparable stocks, (59.921). RENB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.224). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (265.014).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RENB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a financial conglomerate

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Financial Conglomerates
Address
2080 Century Park East
Phone
+1 305 918-1980
Employees
12
Web
https://www.enochianbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RZLT4.300.05
+1.29%
Rezolute
MCO487.542.02
+0.42%
Moody's Corp
HLIT9.31-0.08
-0.90%
Harmonic
RMBS56.55-0.60
-1.05%
Rambus
ACCS9.83-0.32
-3.15%
ACCESS Newswire Inc

RENB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RENB has been loosely correlated with VRCA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RENB jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENB
1D Price
Change %
RENB100%
+2.85%
VRCA - RENB
37%
Loosely correlated
+12.01%
DTIL - RENB
36%
Loosely correlated
-0.97%
TNGX - RENB
34%
Loosely correlated
+0.93%
XBIT - RENB
28%
Poorly correlated
+1.73%
AAVXF - RENB
26%
Poorly correlated
N/A
More